Evidence map›Paper›PMID 31194732›Full record

ArticlePLoS biology2019

Detecting T cell receptors involved in immune responses from single repertoire snapshots.

Mikhail V Pogorelyy, Anastasia A Minervina, Mikhail Shugay, Dmitriy M Chudakov, Yuri B Lebedev, Thierry Mora, Aleksandra M Walczak

Open access · goldAbstract read
In one paragraph

Article in PLoS biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 94 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
94citing papers in PubMed, 1 pooled it
7.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

94 citing papers in PubMed, 1 synthesis or guideline pooled it, 143 citations in OpenAlex.

  1. Resolving SARS-CoV-2 CD4Cell reports. Medicine · 2022
    Pooled it
  2. Trial
  3. Article
  4. T Cell Thoughts.Immunological reviews · 2026
    Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. T Cell Receptor Sharing in Hypersensitivity Pneumonitis.Computational and structural biotechnology journal · 2026
    Article
  13. Article
  14. Machine learning in AIRR diagnostics: Advances and applications.Immunoinformatics (Amsterdam, Netherlands) · 2025
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

34 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 3 countries.

Mikhail V PogorelyyShemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russia.
Anastasia A MinervinaShemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russia.
Mikhail ShugayShemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russia.ORCID 0000-0001-7826-7942
Dmitriy M ChudakovShemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russia.ORCID 0000-0003-0430-790X
Yuri B LebedevShemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russia.ORCID 0000-0003-4554-4733
Thierry MoraLaboratoire de physique statistique, CNRS, Sorbonne Université, Université Paris-Diderot, and École normale supérieure (PSL University), Paris, France.ORCID 0000-0002-5456-9361
Aleksandra M WalczakLaboratoire de physique théorique, CNRS, Sorbonne Université, Université Paris-Diderot, and École normale supérieure (PSL University), Paris, France.ORCID 0000-0002-2686-5702
Centre National de la Recherche Scientifique · FRPrivolzhsky Research Medical University · RUInstitute of Bioorganic Chemistry · RULomonosov Moscow State University · RUPirogov Russian National Research Medical University · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hypervariable T cell receptors (TCRs) play a key role in adaptive immunity, recognizing a vast diversity of pathogen-derived antigens. Our ability to extract clinically relevant information from large high-throughput sequencing of TCR repertoires (RepSeq) data is limited, because little is known about TCR-disease associations. We present Antigen-specific Lymphocyte Identification by Clustering of Expanded sequences (ALICE), a statistical approach that identifies TCR sequences actively involved in current immune responses from a single RepSeq sample and apply it to repertoires of patients with a variety of disorders - patients with autoimmune disease (ankylosing spondylitis [AS]), under cancer immunotherapy, or subject to an acute infection (live yellow fever [YF] vaccine). We validate the method with independent assays. ALICE requires no longitudinal data collection nor large cohorts, and it is directly applicable to most RepSeq datasets. Its results facilitate the identification of TCR variants associated with diseases and conditions, which can be used for diagnostics and rational vaccine design.

Indexed as

Adaptive ImmunityAntigensAntigens, ViralCluster AnalysisComplementarity Determining RegionsHigh-Throughput Nucleotide SequencingHumansImmunotherapyReceptors, Antigen, T-CellSequence Analysis, DNAAntigensAntigens, ViralComplementarity Determining RegionsReceptors, Antigen, T-Cell

Identifiers

PMID31194732
PMCPMC6592544
OpenAlexW2949975396

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.